Digital Tools to Support Self-Management of COPD Patients
Tests a digital package helping adults with COPD use inhalers correctly and on time.
Plain-language title generated from the registry record
Registry title: Digital Therapy in Self-management of COPD Patients
Key facts
- Where
- Beijing, ChinaSee the site
Where in China
- China-Japan Friendship HospitalBeijing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- China-Japan Friendship Hospital
- Trial code
- NCT06776601
- Record updated
- 15 January 2025
- Original description
This project adopts a whole-process digital therapy intervention package composed of an inhalation technique assessment device, an electronic inhalant medication monitoring device and digital software to guide patients use the inhaler correctly personalizedly, record and manage the behavior data of chronic obstructive pulmonary disease (COPD) patients during the use of inhalant medication, and provide personalized reminders and feedback to patients according to the data. The purpose is to analyze whether this digital intervention scheme can reduce the number of acute exacerbations of COPD, improve the management effect of COPD, and reduce the burden of disease by improving the medication compliance of COPD patients.Read full original descriptionShow less
Digital Therapy in Self-management of Chronic Obstructive Pulmonary Disease Patients：A Prospective, Open-labled, Multicenter Randomized Controlled Clinical Study.
This project adopts a whole-process digital therapy intervention package composed of an inhalation technique assessment device, an electronic inhalant medication monitoring device and digital software to guide patients use the inhaler correctly personalizedly, record and manage the behavior data of chronic obstructive pulmonary disease (COPD) patients during the use of inhalant medication, and provide personalized reminders and feedback to patients according to the data. The purpose is to analyze whether this digital intervention scheme can reduce the number of acute exacerbations of COPD, improve the management effect of COPD, and reduce the burden of disease by improving the medication compliance of COPD patients.
Inclusion: Patients diagnosed with COPD; Aged 40 and above; Had one or more severe acute exacerbations in the past year, and be in stable condition for the last 4 weeks; Can operate a smartphone proficiently; Take inhalation medication suits for the inhalation monitoring device as treatment; Fully understand and be willing to sign the informed consent form.
Exclusion: Undergone thoracic, abdominal or ophthalmic surgery in recent 3 months; ABS allergy history; Certain comorbidities (e.g. unstable coronary complications); Pregnant or lactating women.